SCHEMBL6001072

SCHEMBL6001072

[CH2]Nc1ccc2occc2c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.46
DYRK1A Q13627 6/20 0.43
CDK9 P50750 1/20 0.42
HTR1B P28222 5/20 0.41
EPM2A O95278 1/20 0.41
PTPRC P08575 1/20 0.41
PTPN6 P29350 1/20 0.41
CDC14A Q9UNH5 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
CNR1 P21554 1/20 0.39
IDO1 P14902 1/20 0.37
NAMPT P43490 1/20 0.37
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24783507 0.79 CYP2A6 (0.46) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL13153074 0.79 CYP2A6 (0.46) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL11355784 0.79 DYRK1A (0.46) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL1116477 0.79 HTR1B (0.49) CYP2A6DYRK1ACDK9HTR1BEPM2A
Hydrochloric Acid SCHEMBL7556243 0.78 DYRK1A (0.44) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL10240011 0.75 HTR1B (0.46) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL14635442 0.75 CYP2A6 (0.46) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL20419335 0.75 HTR1B (0.49) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL23055230 0.75 CYP2A6 (0.42) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL27714400 0.75 CYP2A6 (0.55) CYP2A6DYRK1ACDK9HTR1BEPM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed
US-6544978-B2 Treating Alzheimer's disease both prophylactically and therapeutically ATHENA NEUROSCIENCES, INC. 2003-04-08 US disclosed